Cytokinetics
Clinical trials sponsored by Cytokinetics, explained in plain language.
-
Heart Drug's Long-Term safety under the microscope in major study
Disease control ENROLLING_BY_INVITATIONThis study aims to gather long-term safety information on the experimental drug aficamten for people with symptomatic hypertrophic cardiomyopathy (HCM), a condition where the heart muscle thickens. It will follow 900 participants who have already taken aficamten in a previous tri…
Phase: PHASE2, PHASE3 • Sponsor: Cytokinetics • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Major heart drug trial aims to ease strain for thousands
Disease control OngoingThis large, late-stage study is testing whether a new drug called aficamten can improve quality of life and exercise ability for adults with a specific heart condition where the heart muscle is too thick but not blocked. It will compare the drug to a placebo in 500 participants t…
Phase: PHASE3 • Sponsor: Cytokinetics • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC